{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:29:44Z","timestamp":1792114184327,"version":"4.4.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease and other dementias (ADOD) are a leading causes of disability and mortality among older adults worldwide. While the rising burden is recognized, comprehensive analyses of its dynamic growth rates, spatial clustering patterns, and comparative long-term forecasts remain limited, hindering targeted policy response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from the Global Burden of Disease (GBD) 2021 study for individuals aged \u226560\u202fyears across 204 countries (1990\u20132021), we analyzed six burden indicators. We calculated age-standardized rates (ASR) and estimated annual percentage changes (EAPC) to quantify trends. Spatial clustering of EAPC patterns was performed using hierarchical clustering. Future burden to 2050 was projected using both exponential smoothing (ES) and autoregressive integrated moving average (ARIMA) models, with comparative analysis across sex, age, and Socio-demographic Index (SDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 1990 to 2021, global ADOD burden increased markedly in absolute terms. EAPC analysis revealed accelerated annual growth (&amp;gt;1%) in East Asia and Eastern Europe, surpassing the global average. Spatial clustering identified four distinct geographic archetypes, with rapid-growth clusters spanning middle-income regions in Latin America and Southeast Asia. Women and adults aged \u226580\u202fyears, especially those \u226595, bore a disproportionately high and increasing burden. Both ES and ARIMA models projected a continued rise in absolute burden to 2050, forecasting a near-doubling of the disease burden (DALYs) among women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The global ADOD burden is escalating with pronounced dynamic heterogeneity in growth velocity and distinct spatial patterns. Our multi-model projections warn of a mounting crisis, disproportionately impacting women, the oldest-old, and rapidly aging middle-income regions. Public health strategies must evolve from static assessments to dynamic surveillance and geographically tailored interventions, with urgent investment in prevention and care systems in high-growth clusters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1661370","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:44:04Z","timestamp":1769755444000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Dynamic trends, spatial clustering, and multi-model projections of the global burden of Alzheimer\u2019s disease and other dementias: an analysis of GBD 1990\u20132021 data to 2050"],"prefix":"10.3389","volume":"18","author":[{"given":"Fangfang","family":"Xiang","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.14283\/jpad.2023.120","article-title":"Systematic and comparative analysis of the burden of Alzheimer\u2019s disease and other dementias in Mexico. Results at the national and subnational levels, 1990-2019","volume":"10","author":"Agudelo-Botero","year":"2023","journal-title":"J. Prev Alzheimers Dis."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41582-024-00962-7","article-title":"Dementia is a neglected noncommunicable disease and leading cause of death","volume":"21","author":"Arthurton","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.14283\/jpad.2022.84","article-title":"The DIAN-TU next generation trial: design of a global clinical trial for autosomal dominant Alzheimer's disease","volume":"10","author":"Bateman","year":"2023","journal-title":"J. Prev Alzheimers Dis."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3233\/JAD-240467","article-title":"Patterns and trends in the burden of Alzheimer's disease and related dementias in China (1990-2021) and predictions to 2040","volume":"105","author":"Chen","year":"2025","journal-title":"J Alzheimer's Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41582-023-00790-6","article-title":"Early-onset dementia: a call for a tailored approach","volume":"19","author":"De Vugt","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30237-0","article-title":"The burden of neurological diseases in Europe: an analysis for the global burden of disease study 2017","volume":"5","author":"Deuschl","year":"2020","journal-title":"Lancet Public Health"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.1097\/JS9.0000000000002460","article-title":"Mortality from Alzheimer's disease and other dementias and its heterogeneity across states in India: findings from GBD 2021 study","volume":"111","author":"Fang","year":"2025","journal-title":"Int. J. Surg."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jamaneurol.2020.4717","article-title":"Burden of neurological disorders across the US from 1990-2017: a global burden of disease study","volume":"78","author":"Feigin","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(22)00002-5","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability, and years of life lost for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1016\/S2468-2667(24)00278-X","article-title":"Three decades of population health changes in Japan, 1990-2021: a subnational analysis for the global burden of disease study 2021","volume":"10","year":"2025","journal-title":"Lancet Public Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/S2666-7568(24)00154-7","article-title":"Incidence, prevalence, and disability-adjusted life years of early-onset dementia from 1990 to 2021: a global analysis","volume":"5","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"100122","DOI":"10.14283\/jpad.2025.100122","article-title":"The disease burden, risk factors and future predictions of Alzheimer's disease and other types of dementia in Asia from 1990 to 2021","volume":"12","author":"Guo","year":"2025","journal-title":"J. Prev Alzheimers Dis."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12916-025-04169-w","article-title":"Trend analysis and future predictions of global burden of Alzheimer\u2019s disease and other dementias: a study based on the global burden of disease database from 1990 to 2021","volume":"23","author":"Hao","year":"2025","journal-title":"BMC Med."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2021.2161","article-title":"Global prevalence of young-onset dementia: a systematic review and meta-analysis","volume":"78","author":"Hendriks","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"171739","DOI":"10.1016\/j.scitotenv.2024.171739","article-title":"Effect of ambient ozone pollution on disease burden globally: a systematic analysis for the global burden of disease study 2019","volume":"926","author":"Hu","year":"2024","journal-title":"Sci. Total Environ."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cger.2014.03.003","article-title":"Dementia and cognitive impairment: epidemiology, diagnosis, and treatment","volume":"30","author":"Hugo","year":"2014","journal-title":"Clin. Geriatr. Med."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"102124","DOI":"10.1016\/j.arr.2023.102124","article-title":"Global, regional, and national prevalence of hearing loss from 1990 to 2019: a trend and health inequality analyses based on the global burden of disease study 2019","volume":"92","author":"Jiang","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"937486","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40779-024-00416-8","article-title":"Epidemiological trends of subarachnoid hemorrhage at global, regional, and national level: a trend analysis study from 1990 to 2021","volume":"11","author":"Lv","year":"2024","journal-title":"Mil. Med. Res."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1002\/alz.13058","article-title":"Consideration of sex and gender in Alzheimer\u2019s disease and related disorders from a global perspective","volume":"19","author":"Mielke","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41591-022-01920-1","article-title":"The global burden of disease study at 30 years","volume":"28","author":"Murray","year":"2022","journal-title":"Nat. Med."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00158-2","article-title":"Findings from the global burden of disease study 2021","volume":"403","author":"Murray","year":"2024","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/09540261.2023.2206112","article-title":"The epidemiology of frontotemporal dementia and early-onset dementias: a comparative analysis","volume":"35","author":"Onyike","year":"2023","journal-title":"Int. Rev. Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/STROKEAHA.122.038548","article-title":"Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030","volume":"54","author":"Pu","year":"2023","journal-title":"Stroke"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2174\/1570159X18666200317141517","article-title":"Neurodegenerative pathways in Alzheimer's disease: a review","volume":"19","author":"Ramachandran","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/ijms24010102","article-title":"Pathogenesis of Alzheimer's disease","volume":"24","author":"Rostagno","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(20)30243-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e5965","DOI":"10.1002\/gps.5965","article-title":"Research evaluating the effectiveness of dementia interventions in low- and middle-income countries: a systematic mapping of 340 randomised controlled trials","volume":"38","author":"Salcher-Konrad","year":"2023","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(21)00576-6","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2471\/BLT.23.290466","article-title":"Health system preparedness for healthy ageing: a scoping review","volume":"102","author":"Sheeh","year":"2024","journal-title":"Bull. World Health Organ."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5535\/arm.2022.46.2.53","article-title":"Dementia epidemiology fact sheet 2022","volume":"46","author":"Shin","year":"2022","journal-title":"Ann. Rehabil. Med."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1016\/S2214-109X(20)30093-4","article-title":"Prediction of dementia risk in low-income and middle-income countries (the 10\/66 study): an independent external validation of existing models","volume":"8","author":"Stephan","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/JAD-150073","article-title":"Prevalence of dementia in people aged 60 years and above: results from the WiSE study","volume":"47","author":"Subramaniam","year":"2015","journal-title":"J Alzheimer's Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"102713","DOI":"10.1016\/j.eclinm.2024.102713","article-title":"Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021","volume":"74","author":"Sun","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1017\/S1041610211000591","article-title":"Caregivers' perspectives on the pre-diagnostic period in early onset dementia: a long and winding road","volume":"23","author":"Van Vliet","year":"2011","journal-title":"Int. Psychogeriatr."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"100842","DOI":"10.1016\/j.lanepe.2024.100842","article-title":"Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050","volume":"38","author":"Wafa","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1159\/000542313","article-title":"Global burden of Alzheimer's disease and other dementias during 1990-2021: a global burden of disease and risk factors study 2021-based study","author":"Wang","year":"2025","journal-title":"Neuroepidemiology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e2141","DOI":"10.1212\/WNL.0000000000207894","article-title":"Burden of common neurologic diseases in Asian countries, 1990-2019: an analysis for the global burden of disease study 2019","volume":"100","author":"Wang","year":"2023","journal-title":"Neurology"},{"key":"ref43","article-title":"Global status report on the public health response to dementia","year":"2021"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12939-025-02320-0","article-title":"Epidemiological and sociodemographic transitions in the global burden and risk factors for Alzheimer's disease and other dementias: a secondary analysis of GBD 2021","volume":"24","author":"Xu","year":"","journal-title":"Int. J. Equity Health"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"04156","DOI":"10.7189\/jogh.15.04156","article-title":"Global incidence trends and projections of Alzheimer disease and other dementias: an age-period-cohort analysis 2021","volume":"15","author":"Xu","year":"","journal-title":"J. Glob. Health"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1159\/000543827","article-title":"Trends of Alzheimer's disease and other dementias with socioeconomic insights: an age-period-cohort analysis and forecasts for 2046","author":"Zeng","year":"2025","journal-title":"Neuroepidemiology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1186\/s12888-024-04733-4","article-title":"Global burden of Alzheimer's disease and other dementias attributed to metabolic risks from 1990 to 2021: results from the global burden of disease study 2021","volume":"24","author":"Zhang","year":"","journal-title":"BMC Psychiatry"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1186\/s12889-024-18456-x","article-title":"Global burden of low vision and blindness due to age-related macular degeneration from 1990 to 2021 and projections for 2050","volume":"24","author":"Zhang","year":"","journal-title":"BMC Public Health"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1097\/JS9.0000000000002441","article-title":"Global, regional, and national burden of brain and central nervous system cancer: a systematic analysis of incidence, deaths, and DALYS with predictions to 2040","volume":"111","author":"Zhang","year":"2025","journal-title":"Int. J. Surg."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1661370\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:44:06Z","timestamp":1769755446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1661370\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":49,"alternative-id":["10.3389\/fnagi.2026.1661370"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1661370","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"1661370"}}